Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients
University of Utah · with National Cancer Institute (NCI), University of New South Wales · NCT06875700
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 300
- US sites recruiting
- 1
- Study start
- July 9, 2024
- Record last updated
- June 13, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Genomic research has shown that a portion of leiomyosarcomas can be attributed to an underlying cancer predisposition syndrome. However, the optimal approach for incorporating germline testing into the care of these patients. This study is assessing the beliefs about the heritability of leiomyosarcoma and other cancer risks, and attitudes towards germline testing among leiomyosarcoma patients.
Conditions: Leiomyosarcoma
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion LMS Proband
- Actionable germline PV detected in the research context
- Living
- No prior germline testing for this PV
- Able to speak and read English
- Mentally competent
- Age 18 or older
Relative of LMS Proband
- 25-50% chance for having inherited the PV
- No prior germline testing for this PV
- Able to speak and read English
- Mentally competent
- Age 18 or older
Exclusion (both cohorts)
- \<18 years
- Unable to read or write
Recruiting US locations
Huntsman Cancer Institute at the University of Utah
Salt Lake City, UT 84112
Site contact: Wendy K Kohlmann, MS · 801-587-5556 · wendy.kohlmann@hci.utah.edu
Study contacts (from the official record)
- Gregg Wood · 8016464215 · gregg.wood@hci.utah.edu
Similar studies in Utah
All healthy volunteers studies in Utah →- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- South Jordan, UT + 6 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of LY4088044 in Healthy Participants
Eli Lilly and Company
- Location
- Salt Lake City, UT + 1 other US site
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)
Gilead Sciences
- Location
- Salt Lake City, UT + 2 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1/Phase 2
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Atavistik Bio, Inc
- Location
- Salt Lake City, UT + 5 other US sites
- Eligibility basics
- Ages 18+